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Control of gait is usually altered following stroke, and it may be further compromised by overexertion and fatigue. This study
aims to quantitatively assess patients’ gait stability during six-minute walking, measuring upper body accelerations of twenty
patients with stroke (64 ± 13 years old) and ten age-matched healthy subjects (63 ± 10 years old). Healthy subjects showed a
steady gait in terms of speed and accelerations over the six minutes. Conversely, the patients unable to complete the test (n = 8)
progressivelyreducedtheirwalkingspeed(−22±11%,conﬁdenceintervalCI95%: −13, −29%,P = 0.046).Patientsabletocomplete
the test (n = 12) did not vary their walking speed over time (P = 0.493). However, this ability was not supported by an adequate
capacity to maintain their gait stability, as shown by a progressive increase of their upper body accelerations (+5±11%, CI95%: −1;
+12%, P = 0.010). Walking endurance and gait stability should be both quantitatively assessed and carefully improved during the
rehabilitation of patients with stroke.
1.Introduction
The recovery of walking ability is one of the most relevant
functional targets after a cerebrovascular event, but this goal
is generally obtained by only 50–60% of patients [1]. In
particular, Paolucci and colleagues showed that at discharge
from a rehabilitation hospital about 5% of patients with
stroke were independent even in stair climbing and 9% were
able to walk outside, 14% to walk inside, and 27% to walk
with cane or other aid, while 45% remained in wheelchair
[2].
Prolonged walking in living environment is even more
challenging than short distances walked in hospital settings.
Furthermore, overexertion can be detrimental for physical
and mental conditions of people with stroke: for these
patients, fatigue prevalence has been estimated to be up to
70% [3, 4]. Fatigue can be deﬁned as a feeling of lack of
energy and weariness following a period of exertion, and it
is characterized by a decreased capacity of work and reduced
eﬃciency to respond to stimuli [5]. All these factors put
the individuals with stroke at great risk of falling during
prolonged walking [6]. Despite that the eﬀects of fatigue,
induced by extended eﬀortful activity, have been investigated
in relationship to spatiotemporal gait parameters [7, 8]a n d
oxygen consumption [5] in people with stroke, far too little
attention has been paid to the relationship between walking
endurance and gait stability.
Gait dynamic stability could be deﬁned as the capacity to
move the body segments in a coordinated fashion so that the
body could be displaced with a proper speed (i.e., functional
to the required task, such as crossing the road safely) mini-
mizing upper body oscillations [9, 10]. So, gait stability can
be suitably assessed by measuring upper body accelerations
[9], in terms of their dispersion and smoothness of upper
body walking patterns [10–12]. In fact, in an unstable gait,
walking speed ﬂuctuates, causing higher accelerations and
hence inertial forces and perturbations that need to be
controlled.
Theaimofthisstudyistoquantifythepotentialeﬀectsof
fatigue, induced by eﬀortful walking, on gait dynamic stabil-
ity of patients with stroke. The hypothesis that we wanted to
test was if gait stability is reduced during prolonged walking2 Stroke Research and Treatment
in people with subacute stroke. To achieve this goal, we have
measured upper body accelerations during the six-minute
walking test performed by ambulatory inpatients.
2.MaterialandMethods
2.1. Participants. Twenty patients with stroke and ten age-
matched healthy subjects were enrolled in this study (see
Table 1 reporting their demographic and clinical charac-
teristics). The patients were tested the day before their
dismissal from a rehabilitation hospital. Exclusion criteria
were inability to walk, severe cognitive impairment, med-
ical contraindications to exercise training, other chronic
disabling pathologies (such as osteoarthritis and chronic
inﬂammatory rheumatic diseases), orthopedic injuries, and
hemispatial neglect. This study was approved by the Local
Ethical Committee, and informed consent was obtained
from each participant.
2.2. Clinical Assessment. To assess the independency in activ-
ities of daily living and the walking ability of our patients, we
administeredthemtheBarthelIndex(BI)andtheFunctional
Ambulation Classiﬁcation (FAC), respectively. BI is one of
the best known and commonly used scales to assess the
degree of independence a patient demonstrates in various
activities of daily living, including mobility and transfers (in
particular, bowel and bladder function, grooming, toilet use,
feeding, transfers, mobility, dressing, climbing stairs, and
bathing). Its total score ranges from 0 (total dependence) to
100(totalindependence)[13].FACisasix-pointhierarchical
rating scale that reﬂects the amount of assistance a person
requires to walk. This scale allows to easily classify patients
in respect of their walking ability, with maximum score
identifying a person able to ambulate independently on
nonlevel surfaces [14]. The median values (ﬁrst, third
quartiles) of these scales are reported in Table 1.
2.3. Walking Endurance Assessment. The six-minute walking
test (6MWT) was used to measure walking endurance, as
usually done in clinical settings [6, 8, 15, 16]. Participants
were asked to cover the maximum distance in six minutes
self-selecting their speed to do it. They were instructed that
they could slow down and rest if necessary and then start
again to walk. Patients were allowed to use a cane or a
walker and/or to perform the test under physiotherapist
supervision, if needed (slight contact might have been
required at times). All the participants (patients and healthy
subjects) were asked to walk with their common shoes for
6 minutes along a 20m level walkway, from one extreme
to another, in the rehabilitation gym of our hospital. They
were told about the lasting time at the third and ﬁfth minute
of walking [8]. At the end of test, the walked distance was
measured. This distance and the distances walked at the
end of each one of the six minutes were evaluated using
tape strips ﬁxed on the ground every 2.5m of the walkway.
Patients able to walk for 6 minutes were grouped in PG1,
whereas patients unable to complete the test were grouped
in PG2.
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Figure 1: The acceleration signal along laterolateral direction of
a patient. The grey large bands highlight the analysed part of the
signal for each one of the 6 minutes of the test. The thin red lines
indicate the end of each 20m lap.
2.4. Gait Stability Assessment. During the 6MWT, the partic-
ipants wore an elastic belt including a light wearable inertial
sensor device (FreeSense, Sensorize s.r.l., Rome; sampling
frequency = 100Hz, weight = 93g) located on their back
in correspondence of L2-L3 spinous processes, close to
their body centre of mass. This device contains a triaxial
accelerometer to separately measure three accelerations, each
one along one of the three body axes (anteroposterior AP,
laterolateral LL, and craniocaudal CC).
Accelerometersignalswere20Hzlow-passﬁltered,trans-
formed to give a mean equal to zero, and summarized in
their root mean square (RMS) [10–12]. RMS is a measure of
acceleration dispersion and therefore of the smoothness of
movement patterns. This makes RMS the parameter most
commonly used to assess gait stability by means of accel-
erometry [9].
For each one of the six minutes of walking, the mean
walking speed was computed as the meters walked in that
minute divided into 60s, and the mean RMS was computed
on the accelerometric signals recorded in a central part of
the linear walking performed in that minute (see Figure 1).
Conversely, accelerometric data recorded during the two
turning parts of the walkway were not analysed.
2.5. Statistical Analysis. Mean ± standard deviation and
95% conﬁdence interval (CI95%) have been computed for
continuous measures and median and 1st and 3rd quartiles
forscalescores.Analogously, t-testwasusedforcomparisons
between two continuous measures (age, days, height, and
body mass index), Mann-Whitney u test for scale scores (BI
and FAC), and χ2 test for binary variables (gender, side of
hemiparesis, and types of stroke). The diﬀerences between
walkingspeedsrecordedatthe1stminuteandthe6thminute
for each subgroup of participants were assessed by means of
paired t-tests.
Ananalysisofvariance(ANOVA)wasperformedinorder
to compare the values of walked distance and walking speeds
among the three groups (between subjects factor), followed
by post hoc comparison performed with Tukey’s test (see
Table 2).
A repeated measure ANOVA was performed on the RMS
values of participants able to complete the test (PG1 and
CG) to assess the changes over time (within-factor: 1, 2, 3, 4,
5, and 6 minutes) and the eﬀects of group (between-factor:
PG1, CG) and body axis (between-factor: AP, LL, and CC).
Conversely, for PG2, in which not all subjects walked forStroke Research and Treatment 3
Table 1: Demographic and clinical characteristics of participants. Mean ± standard deviation (95% conﬁdence interval) or median (ﬁrst
and third quartiles) of demographic characteristics, clinical features and scale scores at the moment of the 6MWT. The fourth and the
last columns report the P values obtained by t test for continuous measures, Mann-Whitney u test for BI and FAC, and χ2 test for side of
hemiparesis and types of stroke.
Characteristics CG PG P PG1 PG2 P
(n = 10) (n = 20) CG versus PG (n = 12) (n = 8) PG1 versus PG2
Age (years old) 62.8 ± 9.7
(56.8;68.8)
64.4 ± 13.0
(58.7;70.1) 0.734 62.7 ± 14.7
(54.4;70.1)
67.0 ± 10.0
(59.8;74.2) 0.468
Height (m) 1.68 ± 0.10
(1.61;1.74)
1.69 ± 0.11
(1.64;1.74) 0.795 1.69 ± 0.13
(1.62;1.76)
1.69 ± 0.09
(1.63;1.75) 0.975
Body mass Index
(kg/m2)
25.5 ± 2.4
(24.0;27.0)
26.29 ± 4.17
(24.5;28.1) 0.594 26.86 ± 4.33
(24.4;29.3)
25.43 ± 4.04
(22.6;28.2) 0.469
Women 5 6 0.284 42 0.690
Men 5 14 8 6
Time from the event
(days) — 132 ± 103
(86.9;177.1) — 101 ± 36
(80.6;121.4)
180 ± 149
(76.7;283.3) 0.091
Length of stay (days) — 92 ± 41
(74.0;110.0) — 83 ± 32
(64.9;101.1)
104 ± 51
(68.7;139.3) 0.277
Barthel index — 60 — 70 46 0.341
(44;88) (50;88) (38;73)
Functional
Ambulation
Classiﬁcation
— 4 — 43 0.327
(2;5) (3;5) (2;4)
Right —
12 — 75 0.852
Left hemiparesis 8 5 3
Ischemic — 18 — 11 7 0.761
haemorrhagic 2 1 1
the same time, paired t-test was performed to compare the
RMS values recorded at the 1st and at the last minute of their
test.Thelinearﬁtandrelevantdeterminationcoeﬃcient(R2)
were computed for assessing the relationship between RMSs
and time. For all the tests, the signiﬁcance level was set at
0.05.
3. Results
3.1. Clinical Tests, Gait Speed, and Walking Endurance.
Twelve of the twenty patients were able to complete the
6MWT (subgroup PG1) and eight patients asked to deﬁni-
tively stop the test before its planned conclusion (PG2).
The clinical characteristics of PG1 and PG2 are summarized
in Table 1. No signiﬁcant clinical diﬀerences were found
between these two groups, although the clinical picture of
PG2 was quite worse (older, lower BI and FAC scores).
In terms of gait performance, a signiﬁcant diﬀerence was
observedintermsofwalkeddistanceamongthethreegroups
(Table 2). Healthy subjects covered a signiﬁcantly longer
distance than that covered by PG1 (P < 0.001) and PG2
(P < 0.001), and PG1 walked signiﬁcantly more than PG2
(P = 0.007). On the other hand, the mean walking speed,
computed over the entire test, was not statistically diﬀerent
between the two groups of patients (but both lower than that
of CG, P < 0.001). This may be explained by the fact that the
higher distance covered by PG1 in respect of PG2 was mainly
due to the longer time spent walking (360s for PG1 versus
245 ± 67s for PG2). However, the walking speed recorded
in the last minute of the test was signiﬁcantly lower in PG2
t h a ni nP G 1( s e eT a b l e2). It was due to a speed reduction
observed in all the subjects of PG2 between the ﬁrst and the
last minutes of walking (mean: −22 ± 11%; P = 0.046, paired
t-test). The same analysis performed on PG1 (+1 ± 11%,
P = 0.493) and CG (−1 ± 7%, P = 0.537) did not show any
signiﬁcant change in terms of walking speed over the course
of the test.
3.2. Gait Stability Assessment. Despite the reduction of walk-
ing speed observed in PG2, their acceleration RMSs were not
reduced between the ﬁrst and the last minutes of the test
(P > 0.05 for all the three RMSs measured along the three
body axes). Conversely, 8 out of 12 patients able to complete
the test showed an increase of accelerations at least along 2
body axes between the 1st and the 6th minutes of the test.
It resulted in a mean progressive increment of all the RMS
values of PG1 (about +5%, signiﬁcant for RMSLL:+ 7± 11%,
P =0.048),notobservedinCG(about −1%).Figure2clearly
shows this mean increment of acceleration in PG1; however
5outofthese12patientsshowedareductionoftheirwalking
speed during the last minute of the test. A repeated measure
ANOVA performed on all the participants who walked for
all the 6 minutes (PG1 and CG) showed that the interaction
betweentimeandgroupsigniﬁcantlyaﬀectedtheRMSvalues
(F = 3.082, P = 0.010), whereas neither the main factor time
(F = 1.981, P = 0.081) nor its interaction with body axis has4 Stroke Research and Treatment
Table 2:Gaitparameters.Mean ±standarddeviation(CI95%)ofgaitparametersrecordedduring6MWTforthethreegroupsofparticipants.
The last two columns reported the statistical analyses. For PG2, the last minute walking speed was the minute before stopping.
Gait parameters
PG1 PG2 CG
Analysis
(n = 12) (n = 8) (n = 10) ANOVA Post-hoc
PG1, PG2, CG PG1 versus PG2
Walked distance (m) 226 ± 111 94 ± 73 413 ± 57 F = 31.03 P = 0.007
(163;289) (43; 144) (378;448) P < 0.001
Walking speed (m/s) 0.63 ± 0.31 0.37 ± 0.25 1.15 ± 0.16 F = 22.72 P = 0.082
(0.45;0.81) (0.20;0.54) (1.04;1.26) P < 0.001
1st minute 0.62 ± 0.30 0.43 ± 0.30 1.17 ± 0.18 F = 19.69 P = 0.271
Walking speed (m/s) (0.45;0.79) (0.22;0.64) (1.05;1.29) P < 0.001
last minute 0.64 ± 0.32 0.32 ± 0.18 1.16 ± 0.13 F = 28.29 P = 0.019
Walking speed (m/s) (0.46;0.82) (0.20;0.44) (1.07;1.25) P < 0.001
a signiﬁcant eﬀect on the acceleration RMSs (F = 1.810, P =
0.058).
4. Discussion
In this study, we observed a progressive reduction of gait
dynamic stability in patients with stroke during prolonged
walking. To test the relationship between walking endurance
and gait stability, we compared the performances of inpa-
tients with those of an age- and height-matched group of
healthy subjects, combining the 6-minute walking test with
the measure of upper body accelerations.
Asexpected,thewalkeddistanceattheendofthetestand
the mean walking speed were both lower in patients than in
healthysubjects.Thelowerwalkingspeedofpatientsimplied
lower accelerations, facilitating their control of upper body
stability[9,11].Inthisstudy,theneedofRMSnormalization
to compare populations walking at diﬀerent speeds [12]h a s
been avoided by analyzing the within-subject variations of
RMS values along the test.
During the six minutes of the test, neither walking
speed nor trunk accelerations signiﬁcantly varied for control
subjects.Conversely,patientsshowedaprogressivereduction
of their walking speed and/or gait stability.
In healthy subjects, it was already found that a reduced
gait velocity results in a corresponding reduction of accel-
eration amplitudes [9]. However, this association between
velocity and acceleration was found altered in our patients
during the 6MWT. In fact, despite the systematic speed
r e d u c t i o no b s e r v e di nP G 2 ,t h e i rt r u n ka c c e l e r a t i o n sw e r e
not reduced during the test. On the other hand, this
association resulted reduced also in patients able to complete
the test (PG1). In fact, they were able to maintain their
self-selected walking speed over the entire test, but many of
them also showed a progressive increment of upper body
accelerations. The speed reduction observed in PG2 without
any acceleration decrease and the increase of upper body
accelerations mainly observed in PG1 keeping constant their
walking speed indicate that the patients’ walking endurance
and gait stability were challenged during this test [17].
Our results suggest that patients used two possible
alternative strategies to perform the 6MWT. Some of them
were able to keep their speed quite constant during walking,
despite a slight but progressive reduction of their upper body
stability. These subjects were mainly those of PG1, that is,
the group able to complete the test. Other subjects seemed
to apply a compensation strategy based on the reduction of
their walking speed. It probably facilitated the management
of their progressive reduction of gait stability during this
eﬀortful walking task. As stated above, the reduction of
walking speed is, in fact, a suitable strategy for reducing
upper body accelerations [9, 11]. This last strategy has been
observed especially in those patients who asked to stop the
test before its planned conclusion.
In previous studies, for patients with chronic stroke per-
forming the 6MWT, neither diﬀerences in velocities for each
1-minute interval [18]n o rd i ﬀerences in energy consump-
tion [5] were found signiﬁcant over the course of the walk.
The eﬀects of fatigue were probably not highlighted by these
measures [18]. Conversely, changes in gait symmetry [7]a n d
in unaﬀected lower limb extensor power [5]w e r ef o u n d
associated with fatigue mechanisms over some minutes of
walking.
However, far too little attention has been paid to the
reduction of gait stability during prolonged walking, which
may potentially increase the risk of falls [9]. In fact, the
correlations between upper body accelerations and fall risk
have been proven [19]. Falls are one of the most important
problems among people after stroke, implying physical
and psychological consequences associated with restricted
a c t i v i t ya sar e s u l to ff r a c t u r e s[ 20] and fear of new falls [21].
During level walking, the main causes of falling are quick
walking speed in respect of the actual patient’s locomotor
capacity, anterior body mass carriage, and step timing delays
[22, 23]. In daily living environment, it is conceivable that
the patients who self-selected to keep constant their walking
speed in spite of an increase of their upper body instabilities
may be exposed to a high risk of fall.
In fact, in this study, we found an increment of patients’
upper body accelerations, especially along anteroposterior
and laterolateral directions over six-minute walking. TheseStroke Research and Treatment 5
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Figure 2: Acceleration RMS for PG1 ((a), (c), and (e)) and CG ((b), (d), and (f)) along anteroposterior ((a) and (b)), laterolateral ((c) and
(d)) and craniocaudal ((e) and(f)) directions. Regression lines and relevant coeﬃc i e n to fd e t e r m i n a t i o nR2 are also reported.
accelerations have already been showed as the most infor-
mative for assessing the gait stability and also the most
correlated with the risk of fall [11, 23]. These ﬁndings seem
to be consistent with the changes in kinematic [7]a n d
kinetic [5] gait parameters already observed during 6MWT
performed by people with stroke. Further studies on wider
samples of patients should investigate whether this reduction
of gait stability is progressive, as our results seem to show, or
it happens only after an identiﬁable threshold. On the other
hand, the reduction of walking speed probably used by some
patients to compensate the reduction of gait stability could
be anyway dangerous during outdoor walking. By way of
example, an adequate gait velocity can be needed to perform
some speciﬁc tasks, such as crossing the street during the
green phase of traﬃc lights [24].
The main limitation of our study is the reduced size
of healthy and patient samples especially in respect of the
many features of stroke. Wider samples are needed in future
studies to further explore the diﬀerences between patients
who could and those who could not complete the 6-minute
walking test. Another important aspect that needs to be
further investigated is the stabilizing eﬀect of the use of a
cane or of the therapist’s touch during walking. It should
be noted that in our study the needs of external helps were
similar in the two subgroups of patients (as shown by similar
autonomy walking level: see values of FAC scores in Table 1),
aﬀecting the upper body accelerations in a similar manner.
Finally,thediﬃcultiesencounteredbyparticipantsturningat
the end of each lap and the upper body accelerations during
turning have been not taken into account in this study.
Further researches should deeply investigate this aspect of
walking component that can lead to diﬀerences in upper
body accelerations. Despite these limitations, our study pro-
vided important information about the relationship between
upper body dynamic stability and walking endurance.
Our results should be read in conjunction with those of
Lerdal and colleagues in which it has been shown how an
increased mobility may increase exposure to fall opportuni-
ties [3]. Walking speed, gait stability, and endurance should
be hence quantitatively assessed and improved during reha-
bilitation in order to allow patients to walk in a functional
and safe manner. Furthermore, accelerometry has been
recently proposed for assessing the patients’ performances
during robotic gait training [25] and daily life activities [26].
Thequantitativeassessmentofabilityandstabilityofgaitcan
improve the eﬀectiveness of an intensive training designed
around the actual patient’s locomotor capacity [27] and the
“locomotor awareness” of the patients about his/her abilities
and limits.
5. Conclusion
Patients with stroke showed a reduction of walking speed
and/orareductionofgaitstabilityduringprolongedwalking.
In particular, the patients able to complete the six-minute
walking test maintained a steady speed over the course of
the walk, but their upper body accelerations progressively
increased, exposing them to the risk of falling.6 Stroke Research and Treatment
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